Newsroom

VBI Vaccines News and Media

Newsroom

VBI Vaccines News and Media

Featured Videos

Featured
June 22, 2020

VBI-1901: AACR 2020 Webcast

David E. Anderson, Ph.D., discusses updated Part B data from the VBI's ongoing Phase 1/2a study of VBI-1901.
Featured
October 15, 2016

About Hepatitis B

Hepatitis B is a disease of the liver caused by the hepatitis B virus (“HBV”) characterized by inflammation, injury, and even cell death.
Featured
June 18, 2014

eVLP Platform Technology

VBI’s eVLP Platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines.

News Alerts

Subscribe to Receive VBI Email Alerts

Media Contact

Nicole Anderson
Director, Corporate Communications & Investor Relations
Telephone: (617) 830-3031 x124
Email: ir@vbivaccines.com

Media Kit

Download Media Kit

Recent Press Releases

VBI on Twitter